Therapeutic Innovation & Regulatory Science

10.9k citations
1.4k papers · · active since 2016

Impact in

Papers in

Therapeutic Innovation & Regulatory Science

949 papers receiving 8.1k citations

Peers

Therapeutic Innovation & Regulatory Science
Comparison fields: 5 of 196
  • Statistics and Probability 1.3k
  • Toxicology 444
  • Health Informatics 189
  • Economics and Econometrics 2.5k
  • Geriatrics and Gerontology 189
Replace Clinical Epidemiology with:
Clinical Epidemiology Denmark
Clinical Trials United States
Circulation Cardiovascular Quality and Outcomes United States
CPT Pharmacometrics & Systems Pharmacology United States
Expert Review of Pharmacoeconomics & Outcomes Research United States
Health Technology Assessment United Kingdom
American Society of Clinical Oncology Educational Book United States
Clinics in Laboratory Medicine United States
Pharmaceutical Statistics United States
Personalized Medicine United States
Therapeutic Innovation & Regulatory Science relative to Clinical Epidemiology Denmark Clinical Epidemiology's profile →
Citations per field
00.5×2×2.7×
Clinical Epidemiology · 1×
Citations per year

Countries where authors publish in Therapeutic Innovation & Regulatory Science

Since Specialization
Citations

This map shows the geographic impact of research published in Therapeutic Innovation & Regulatory Science. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Therapeutic Innovation & Regulatory Science with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Therapeutic Innovation & Regulatory Science more than expected).

Fields of papers published in Therapeutic Innovation & Regulatory Science

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Therapeutic Innovation & Regulatory Science. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Therapeutic Innovation & Regulatory Science.

About Therapeutic Innovation & Regulatory Science

The 1.4k papers published in Therapeutic Innovation & Regulatory Science in the last decades have received a total of 10.9k indexed citations . Papers published in Therapeutic Innovation & Regulatory Science usually cover Statistics and Probability (256 papers), Toxicology (69 papers), Economics and Econometrics (413 papers), Medical Terminology (3 papers) and Pharmacology (94 papers) specifically the topics of Health Systems, Economic Evaluations, Quality of Life (316 papers), Statistical Methods in Clinical Trials (252 papers), Pharmaceutical Economics and Policy (196 papers), Biomedical Ethics and Regulation (121 papers), Pharmaceutical studies and practices (114 papers), Ethics in Clinical Research (103 papers), Biosimilars and Bioanalytical Methods (87 papers) and Pharmacovigilance and Adverse Drug Reactions (69 papers). The most active scholars publishing in Therapeutic Innovation & Regulatory Science are Kenneth A. Getz, Nancy A Dreyer, Lode Dewulf, Joseph C. Cappelleri, Stuart Robert Walker, Stella Stergiopoulos, Cheryl D. Coon, Long Chiau Ming, Jonathan P. Jarow and Jan Geißler.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact